Genetic risk factors for inflammatory bowel disease in a North-eastern Mexican population

International Journal of Immunogenetics

Volumn 37, Issue 5, 2010, Pages 355-359

  Garza Gonzalez E ^a   Perez Perez G I ^b   Mendoza Ibarra, S I ^a   Flores Gutierrez J P ^c   Bosques Padilla, F J ^d  

^a Medicina UANL   (Mexico)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HOSPITAL UNIVERSITARIO DR JOSÉ ELEUTERIO GONZÁLEZ   (Mexico)

^d UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DNA EXTRACTION; ENTERITIS; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HOMOZYGOSITY; HUMAN; PRIORITY JOURNAL; PYROSEQUENCING; RISK FACTOR; SEROLOGY; ULCERATIVE COLITIS;

ADULT; AGED; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-10; MALE; MEXICO; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; YOUNG ADULT;

HELICOBACTER PYLORI;

EID: 78651080652     PISSN: 17443121     EISSN: 1744313X     Source Type: Journal    
DOI: 10.1111/j.1744-313X.2010.00932.x     Document Type: Article

References (26)

1. Balding, J., Livingstone, W., Conroy, J., Mynett-Johnson, L., Weir, D.G., Mahmud, N. et al. (2004) Infllammatory bowel disease, the role of inflammatory cytokine gene polymorpisms. Mediators of inflammation, 13, 181.
2. Blaser, M.J., Perez-Perez, G.I., Kleanthous, H., Cover, T.L., Peek, R.M., Chyou, P.H. et al. (1995) Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Research, 55, 2111.
3. De Jager, P.L., Franchimont, D., Waliszewska, A., Bitton, A., Cohen, A., Langelier, D. et al. (2007) The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases. Mediators of inflammation, 8, 387.
4. El-Omar, E.M., Rabkin, C.S., Gammon, M.D., Vaughan, T.L., Risch, H.A., Schoenberg, J.B. et al. (2003) Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology, 124, 1193.
5. Garza-González, E., Bosques-Padilla, F.J., El-Omar, E., Hola, G., Tijerina-Menchaca, R., Maldonado-Garza, H.J. et al. (2005) Role of the polymorphic IL-1B, IL-1RN and TNF-A genes in distal gastric cancer in Mexico. International Journal of Cancer, 114, 237.
6. Gibson, A.W., Edberg, J.C., Wu, J., Westendorp, R.G., Huizinga, T.W. & Kimberly, R.P. (2001) Novel single nucleotide polymorphisms in the distal IL10 promoter affect IL10 production and enhance the risk of systemic lupus erythematosus. Journal of Immunology, 166, 3915-3922.
7. Hendrickson, B.A., Gokhale, R. & Cho, J.H. (2002) Clinical aspects and pathophysiology of inflammatory bowel disease. Clinical Microbiology Reviews, 15, 79.
8. Holler, E., Roncarolo, M.G., Hintermeier-Knabe, R., Eissner, G., Ertl, B., Schulz, U. et al. (2000) Prognostic significance of increased IL10 production in patients prior to allogeneic bone marrow transplantation. Bone Marrow Transplantation, 25, 237.
9. Hume, G.E., Fowler, E.V., Doecke, J., Simms, L.A., Huang, N., Palmieri, O. et al. (2008) Novel NOD2 haplotype strengthens the association between TLR4 Asp299gly and Crohn's disease in an Australian population. Inflammatory Bowel Diseases, 14, 585.
10. Keijsers, V., Verweij, C.L., Westendorp, R.G.J., Breedveld, F.C. & Huizinga, T.W.J. (1997) IL10 polymorphisms in relation to production and rheumatoid arthritis. Arthritis and Rheumatism, 40(Suppl), S179.
11. Koss, K., Satsangi, J., Fanning, G.C., Welsh, K.I. & Jewell, D.P. (2000) Cytokine (TNFα, LTα and IL-10) polymorphisms in inflammatory bowel diseases and normal controls, differential effects on production and allele frequencies. Genes and Immunity, 1, 185.
12. Lin, M.T., Storer, B., Martin, P.J., Tseng, L.H., Gooley, T., Chen, P.J. et al. (2003) Relation of an IL-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation. The New England Journal of Medicine, 349, 2201.
13. Loftus Jr, E.V. (2004) Clinical epidemiology of inflammatory bowel disease, incidence, prevalence, and environmental influences. Gastroenterology, 126, 1504-1517.
14. Lorenz, E., Frees, K.L. & Schwartz, D.A. (2001) Determination of the TLR4 genotype using allele-specific PCR. BioTechniques, 31, 22.
15. Mosser, D.M. & Zhang, X. (2008) Interleukin-10, new perspectives on an old cytokine. Immunological Reviews, 226, 205.
16. Oostenbrug, L.E., Drenth, J.P., de Jong, D.J., Nolte, I.M., Oosterom, E., van Dullemen, H.M. et al. (2005) Association between Toll-like receptor 4 and inflammatory bowel disease. Inflammatory Bowel Diseases, 11, 567.
17. Pérez-Pérez, G.I., Portal-Celhay, C., Bosques-Padilla, F.J. & Garza-González, E. (2007) Development of a protocol of pyrosequencing for determination of the polymorphism at position -31 of the interleukin-1beta gene in the study of risk of development of stomach cancel. Revista Mexicana de Gastroenterolgia, 72, 10.
18. Piodi, L.P., Bardella, M., Rocchia, C., Cesana, B.M., Baldassarri, A. & Quatrini, M. (2003) Possible protective effect of 5-aminosalicylic acid on Helicobacter pylori infection in patients with inflammatory bowel disease. Journal of clinical gastroenterology, 36, 22.
19. Podolsky, D.K. (2002) Inflammatory bowel disease. New England Journal of Medicine, 347, 417-429.
20. Rodriguez-Bores, L., Fonseca, G.C., Villena, M.A. & Yamamoto-Furusho, J.K. (2007) Novel genetic markers in inflammatory bowel disease. World Journal of Gastroenterology, 13, 5560.
21. Sanchez-Munoz, F., Dominguez-Lopez, A. & Yamamoto-Furusho, J.K. (2008) Role of cytokines in inflammatory bowel disease. World Journal of Gastroenterology, 14, 4280.
22. Silverberg, M.S., Satsangi, J., Ahmad, T., Arnott, I.D., Bernstein, C.N., Brant, S.R. et al. (2005) Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease, Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Canadian Journal of Gastroenterology, 19(Suppl A), 5.
23. Turner, D.M., Williams, D.M., Sankaran, D., Lazarus, M., Sinnott, P.J. & Hutchinson, I.V. (1997) An investigation of polymorphism in the interleukin-10 gene promoter. European Journal of Immunogenetics, 24, 1.
24. Väre, P.O., Heikius, B., Silvennoinen, J.A., Karttunen, R., Niemelä, S.E., Lehtola, J.K. et al. (2001) Seroprevalence of Helicobacter pylori infection in inflammatory bowel disease, is Helicobacter pylori infection a protective factor? Scandinavian Journal of Gastroenterology, 36, 1295.
25. Yamamoto-Furusho, J.K. (2009) Clinical epidemiology of ulcerative colitis in Mexico: a single hospital-based study in a 20-year period (1987-2006). Journal of clinical gastroenterology, 43, 221.
26. Yamamoto-Furusho, J.K., Uscanga, L.F., Vargas-Alarcón, G., Ruiz-Morales, J.A., Higuera, L., Cutido, T. et al. (2003) Clinical and genetic heterogeneity in Mexican patients with ulcerative colitis. Human Immunology, 64, 119.